EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Combination therapy dramatically promotes remyelination

Yawen Li, Pingping Li, Yixuan Song, Wenjun Zhang, Xinyue Jiang, Siyi Chen, Wei Luo, Caiyun Ma, Changqing Liu, Jianguo Niu, Aibin Liang, Yarui Du und 2 weitere

Journal of Molecular Cell Biology · 2025

DOI: 10.1093/jmcb/mjaf005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Cell Biology, 2025. Verfasst von Yawen Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histoembryology, Genetics and Developmental Biology, Shanghai Key Laboratory of Reproductive Medicine, Shanghai Jiao Tong University Sc…. Hauptthemen laut MEDLINE: Remyelination, Encephalomyelitis, Autoimmune, Experimental, Myelin Sheath, Multiple Sclerosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis (MS) is an immune-mediated disease in the central nervous system that is characterized by demyelination, axonal degeneration, and progressive neurological disability and is so far incurable. Current medications are predominantly immune-targeted but fail to prevent disease progression due to their inability to actively promote remyelination. Small molecules have been reported to promote myelin regeneration but their therapeutic efficacy is limited by insufficient immune modulation. Thus, the strategies achieving both immunomodulation and active myelin regeneration are highly desired. Here, we investigated a combination therapy (CT) for MS designed to simultaneously modulate immune responses and promote oligodendrocyte precursor cell differentiation and in situ remyelination in an experimental autoimmune encephalomyelitis mouse model. Remarkably, CT suppressed acute inflammatory activity, activated the signaling pathways for myelin development, induced the expression of myelin-related genes, and significantly promoted remyelination and the recovery of motor performance. Furthermore, a reduced immunomodulator dosage or shorter treatment duration with small-molecule drugs achieved comparable symptom reversal. Our findings demonstrate the potential of CT to address complex pathobiology and lay a foundation for developing novel therapeutic strategies for MS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RemyelinationEncephalomyelitis, Autoimmune, ExperimentalMyelin SheathMultiple SclerosisAnimalsMiceMice, Inbred C57BLCell DifferentiationDisease Models, AnimalFemaleDrug Therapy, CombinationCombined Modality TherapyOligodendrocyte Precursor CellsOligodendroglia

Stichwörter der Autor:innen

combination therapydemyelinating diseasesimmune modulationoligodendrocyte precursor cellsremyelinationsmall-molecule drugs

Autor:innen und Institutionen

  • Department of Histoembryology, Genetics and Developmental Biology, Shanghai Key Laboratory of Reproductive Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  • Department of Hematology, Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China.
  • School of Basic Medical Sciences, Kunming Medical University, Kunming 650501, China.
  • Anhui Engineering Research Center for Neural Regeneration Technology and Medical New Materials, School of Life Sciences, Bengbu Medical University, Bengbu 233000, China.
  • Ningxia Key Laboratory of Craniocerebral Diseases of Ningxia Hui Autonomous Region, School of Basic Medical Sciences, Ningxia Medical University, Yinchuan 750004, China.
  • Key Laboratory of Epigenetic Regulation and Intervention, Shanghai Key Laboratory of Molecular Andrology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Aca…

ORCID-Profile: Mingliang Zhang

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Li, Y., Li, P., Song, Y., Zhang, W., Jiang, X., Chen, S., Luo, W., Ma, C., Liu, C., Niu, J., Liang, A., Du, Y., Zhou, B. O., & Zhang, M. (2025). Combination therapy dramatically promotes remyelination. Journal of Molecular Cell Biology. https://doi.org/10.1093/jmcb/mjaf005

Vancouver

Li Y, Li P, Song Y, Zhang W, Jiang X, Chen S, et al. Combination therapy dramatically promotes remyelination. Journal of Molecular Cell Biology. 2025. doi:10.1093/jmcb/mjaf005

BibTeX
@article{Li2025,
  author = {Li, Yawen and Li, Pingping and Song, Yixuan and Zhang, Wenjun and Jiang, Xinyue and Chen, Siyi and Luo, Wei and Ma, Caiyun and Liu, Changqing and Niu, Jianguo and Liang, Aibin and Du, Yarui and Zhou, Bo O and Zhang, Mingliang},
  title = {Combination therapy dramatically promotes remyelination},
  journal = {Journal of Molecular Cell Biology},
  year = {2025},
  doi = {10.1093/jmcb/mjaf005}
}
Kostenlos starten →